mTOR Signaling in Parkinson's Disease

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Mechanistic target of rapamycin (mTOR) regulates cell metabolism and survival.
• Parkinson's disease (PD) involves neuronal cell death and disrupted cellular processes.
• mTOR signaling is increasingly recognized for its role in neurodegenerative diseases.

Purpose of the Study:

• To review the association between mTOR signaling and Parkinson's disease risk factors.
• To discuss the potential therapeutic roles of mTOR in PD pathogenesis.
• To elucidate the molecular mechanisms of mTOR in PD.

Main Methods:

• Literature review of recent research on mTOR and PD.
• Analysis of studies investigating mTOR signaling pathways in PD models.
• Synthesis of findings on mTOR's involvement with PD risk factors.

Main Results:

• Perturbed mTOR signaling is linked to Parkinson's disease.
• Restoring mTOR signaling in PD models shows neuroprotective effects.
• The precise molecular mechanisms of mTOR in PD are still under investigation.

Conclusions:

• mTOR represents a promising therapeutic target for Parkinson's disease.
• Further research is needed to fully understand mTOR's role and optimize therapeutic strategies for PD.
• Targeting mTOR signaling could offer novel treatment avenues for PD patients.